Clinical Trial: Study of SLN12140 in Healthy Adult Participants

U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06945445) titled 'Study of SLN12140 in Healthy Adult Participants' on April 10.

Brief Summary: A randomized, double-blind, placebo-controlled phase I clinical study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of SLN12140 in healthy participants with single subcutaneous/intravenous dose escalation and multiple subcutaneous administrations

Study Start Date: April, 2025

Study Type: INTERVENTIONAL

Condition: Healthy Volunteer

Intervention: DRUG: SLN12140

SLN12140 for sc injection or IV infusion

OTHER: Placebo

Placebo for sc injection or IV infusion

Recruitment Status: NOT_YET_RECRUITING

Sponsor:...